ProjectRD.06.SPR.202699 – A long-term study to assess the safety and efficacy of nemolizumab(CD14152) in subjects with…
Basic data
Acronym:
RD.06.SPR.202699
Title:
A long-term study to assess the safety and efficacy of nemolizumab(CD14152) in subjects with prurigo nodularis (PN)
Duration:
04/05/2020 to 31/12/2022
Abstract / short description:
A Prospective, Multicenter, Long-Term Study to Assess the Safety and
Efficacy of Nemolizumab (CD14152) in Subjects with Prurigo Nodularis
Efficacy of Nemolizumab (CD14152) in Subjects with Prurigo Nodularis
Keywords:
Pruigo nodularis
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
CRC-TR 156 - The Skin as a Sensor and Effector Organ Orchestrating Local and Systemic Immune Responses
Collaborative research centers and transregios
Collaborative research centers and transregios
Cluster of Excellence: Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
Centers or interfaculty scientific institutions
Centers or interfaculty scientific institutions
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
La Tour-de-Peilz, Switzerland